A team from The University of Texas at Austin (TX, USA) are developing a sensor capable of testing for COVID-19 and influenza simultaneously.
Researchers have developed a thread-based bioluminescence sensor capable of detecting antibodies in a finger prick sample of whole blood.
Bioanalytical strategies for PK analysis of antibody–drug conjugate therapeutics using LC–HRMS & LC–MS/MS
Antibody–drug conjugates (ADCs) combine the best of two modalities: toxic efficacy and antibody specificity. This infographic describes various mass spectrometry-based strategies Frontage have successfully applied in the bioanalysis of ADCs for clinical and preclinical studies.
Researchers have developed a quantitative immunochromatographic test, with a new type of membrane test strip, which could aid the early diagnosis of heart attack by identifying markers in blood.
In this interview we talk to Stephane Moreau (Shimadzu, Europe) about his research into nSMOL monoclonal antibody analysis. Stephane discusses the benefits of this technique in comparison with traditional technology like immunoassays.
Drug-target complex specific antibodies: In this interview we talk to Michael Schwenkert (Bio-Rad Laboratories) about the poster he presented at EBF 2017.
Method establishment for discerned immunogenicity assessment of a recombinant glycoprotein containing nonhuman sialic acid Neu5Gc residues
This research article describes a validated electrochemiluminescent method for the detection of antidrug antibodies against both protein and Neu5Gc-containing glycan epitopes.
MorphoSys (Munich, Germany) has announced that its licensee Janssen (Beerse, Belgium) has gained approval for Tremfya® in Europe. The monoclonal antibody is used for the treatment of plaque psoriasis.
Take a look inside Bio-Rad’s custom recombinant antibody facility. Learn from our antibody experts how…
In this review, the authors discuss the use of biomarkers as diagnostic tools for human primary membranous nephropathy. Learn more in this article from Biomarkers in Medicine.